Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer (MVUVLC)
Primary Purpose
Non Small Cell Lung Cancer
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Uniportal VATS
Conventional VATS
Sponsored by
About this trial
This is an interventional treatment trial for Non Small Cell Lung Cancer focused on measuring CVATS, UVATS, perioperative effect, ergonomic influence
Eligibility Criteria
Inclusion Criteria:
- Patients with clinical diagnosis of primary lung cancer with the age between 35 and 75 years old;
- Patients with Tumor size ≤5cm,clinically staged T1-2N0-1M0,prepared for lobectomy and mediastinal lymph node dissection;
- Patients with an American Society of Anesthesiology score of 0-1.
Exclusion Criteria:
- Patients with N2 or N3 positive or distant metastasis.
- Patients who had undergone Neoadjuvant chemotherapy.
- Patients with tumor invasion to the peripheral structures.
- Patients with previous history of thoracic operations.
- Patients with serious thoracic adhesion.
- Patients who will undergo Pneumonectomy, sleeve lobectomy, segmentectomy, wedge resection.
- Patients with preexisting chronic obstructive pulmonarydisease, asthma, or interstitial lung disease;
- Patients with cardiac, hepatic, or renal dysfunction;
Sites / Locations
- The second affiliated hospital Zhejiang university school of medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Conventional VATS
Uniportal VATS
Arm Description
Via conventional VATS lobectomy and systematic lymph node dissection for lung cancer
Via uniportal VATS lobectomy and systematic lymph node dissection for lung cancer
Outcomes
Primary Outcome Measures
short-term quality of life(EQ5D) between the two groups
To observe differences of short-term effects(bleeding volume during operation,operation time, hospital mortality, hospital stay and so on) between two groups.
Secondary Outcome Measures
intra-operative and postoperative complications
Surgical Complications include conversion rate, bleeding, air leakage, pain, cardiac arrhythmias, wound infection, pulmonary complications, pulmonary function will be measured.
lung function
lung function will be measured at pre-operative, 3 weeks, 3 months after surgery
Pain Scores after surgery
Pain Scores will be measured by Brief pain inventory
The surgeon's ergonomic influence during operation(blinks/min)
Spontaneous eye blink rate(NASA Task Load Index,NASA TLX)
Full Information
NCT ID
NCT02462356
First Posted
May 27, 2015
Last Updated
April 14, 2016
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
1. Study Identification
Unique Protocol Identification Number
NCT02462356
Brief Title
Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer
Acronym
MVUVLC
Official Title
A Randomized Controlled Study: the Effect of Multiple-portal VATS Versus Conventional VATS Lobectomy for NSCLC
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2015 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
September 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study evaluate multiple-portal VATS and uniportal VATS lobectomy for NSCLC, half of participants will receive multiple VATS, while the other half will receive uniportal VATS lobectomy.
Detailed Description
Conventional VATS and uniportal VATS lobectomy can be performed each for NSCLC. Conventional VATS lobectomy employ 3 or 4 ports for completing the operation. Usually the camera port is performed at the seventh or eighth intercostals space within the trocar, so it's easy to cause the intercostals nerve and vessel injure, and still create obvious pain.
However, the lobectomy for lung cancer can be accomplished with a single incision. According to the initial results, Uniportal VATS (UVATS) lobectomy procedure has been wide adopted by less acess trauma, relieve postoperative pain. But these were retrospective and descriptive, not randomized study. Further randomized control studies will be required to demonstrate that there are more benefits in UVATS techniques compared with conventional VATS for lobectomy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non Small Cell Lung Cancer
Keywords
CVATS, UVATS, perioperative effect, ergonomic influence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Conventional VATS
Arm Type
Active Comparator
Arm Description
Via conventional VATS lobectomy and systematic lymph node dissection for lung cancer
Arm Title
Uniportal VATS
Arm Type
Experimental
Arm Description
Via uniportal VATS lobectomy and systematic lymph node dissection for lung cancer
Intervention Type
Procedure
Intervention Name(s)
Uniportal VATS
Intervention Description
Uniportal VATS lobectomy and lymph node dissection will be performed in this group
Intervention Type
Procedure
Intervention Name(s)
Conventional VATS
Intervention Description
Conventional VATS lobectomy and lymph node dissection will be performed in this group
Primary Outcome Measure Information:
Title
short-term quality of life(EQ5D) between the two groups
Description
To observe differences of short-term effects(bleeding volume during operation,operation time, hospital mortality, hospital stay and so on) between two groups.
Time Frame
Up to 6 month
Secondary Outcome Measure Information:
Title
intra-operative and postoperative complications
Description
Surgical Complications include conversion rate, bleeding, air leakage, pain, cardiac arrhythmias, wound infection, pulmonary complications, pulmonary function will be measured.
Time Frame
form the day of surgery up to discharege (expected within 1 month)
Title
lung function
Description
lung function will be measured at pre-operative, 3 weeks, 3 months after surgery
Time Frame
pre-operative, 3 weeks, 3 months after surgery
Title
Pain Scores after surgery
Description
Pain Scores will be measured by Brief pain inventory
Time Frame
1, 3 days and 1, 3 months after surgery
Title
The surgeon's ergonomic influence during operation(blinks/min)
Description
Spontaneous eye blink rate(NASA Task Load Index,NASA TLX)
Time Frame
The video is capture every 5 minutes and lasted for 1 minute
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with clinical diagnosis of primary lung cancer with the age between 35 and 75 years old;
Patients with Tumor size ≤5cm,clinically staged T1-2N0-1M0,prepared for lobectomy and mediastinal lymph node dissection;
Patients with an American Society of Anesthesiology score of 0-1.
Exclusion Criteria:
Patients with N2 or N3 positive or distant metastasis.
Patients who had undergone Neoadjuvant chemotherapy.
Patients with tumor invasion to the peripheral structures.
Patients with previous history of thoracic operations.
Patients with serious thoracic adhesion.
Patients who will undergo Pneumonectomy, sleeve lobectomy, segmentectomy, wedge resection.
Patients with preexisting chronic obstructive pulmonarydisease, asthma, or interstitial lung disease;
Patients with cardiac, hepatic, or renal dysfunction;
Facility Information:
Facility Name
The second affiliated hospital Zhejiang university school of medicine
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310000
Country
China
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
33080728
Citation
Yao J, Chang Z, Zhu L, Fan J. Uniportal versus multiportal thoracoscopic lobectomy: Ergonomic evaluation and perioperative outcomes from a randomized and controlled trial. Medicine (Baltimore). 2020 Oct 16;99(42):e22719. doi: 10.1097/MD.0000000000022719.
Results Reference
derived
Learn more about this trial
Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer
We'll reach out to this number within 24 hrs